000			01942 a2200553 4500
005			20250518090935.0
264		0	_c20200921
008			202009s 0 0 eng d
022			_a1573-7241
024	7		_a10.1007/s10557-020-06956-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aXi, Ziwei
245	0	0	_aTicagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention. _h[electronic resource]
260			_bCardiovascular drugs and therapy _c04 2020
300			_a179-188 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aClopidogrel _xadverse effects
650	0	4	_aCoronary Artery Disease _xdiagnostic imaging
650	0	4	_aCoronary Thrombosis _xmortality
650	0	4	_aCytochrome P-450 CYP2C19 _xgenetics
650	0	4	_aFemale
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyocardial Infarction _xmortality
650	0	4	_aPercutaneous Coronary Intervention _xadverse effects
650	0	4	_aPharmacogenomic Variants
650	0	4	_aPlatelet Aggregation Inhibitors _xadverse effects
650	0	4	_aPurinergic P2Y Receptor Antagonists _xadverse effects
650	0	4	_aRegistries
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aStents
650	0	4	_aTicagrelor _xadverse effects
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aZhou, Yujie
700	1		_aZhao, Yingxin
700	1		_aLiu, Xiaoli
700	1		_aLiang, Jing
700	1		_aChai, Meng
700	1		_aYu, Ying
700	1		_aLiu, Wei
773	0		_tCardiovascular drugs and therapy _gvol. 34 _gno. 2 _gp. 179-188
856	4	0	_uhttps://doi.org/10.1007/s10557-020-06956-4 _zAvailable from publisher's website
999			_c30711457 _d30711457